These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19407850)

  • 1. HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus.
    Simões RT; Gonçalves MA; Castelli EC; Júnior CM; Bettini JS; Discorde ML; Duarte G; Quintana SM; Simões AL; Moreau P; Carosella ED; Soares EG; Donadi EA
    Mod Pathol; 2009 Aug; 22(8):1075-82. PubMed ID: 19407850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the association of NKG2C copy number variations with susceptibility to human papillomavirus-induced cervical lesions.
    Vilchez JR; Torres-Moreno D; Martínez-Senac MM; Trujillo-Santos J; Conesa-Zamora P
    Hum Immunol; 2013 Oct; 74(10):1352-6. PubMed ID: 23911737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of HLA-G 3' untranslated region polymorphisms in human papillomavirus infection.
    Bortolotti D; Gentili V; Rotola A; Di Luca D; Rizzo R
    Tissue Antigens; 2014 Feb; 83(2):113-8. PubMed ID: 24397524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
    Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
    Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between human leukocyte antigen class II alleles and human papillomavirus-mediated cervical cancer in Indian women.
    Kohaar I; Hussain S; Thakur N; Tiwari P; Nasare V; Batra S; Singh V; Bhambani S; Das BC; Sarkar DP; Bharadwaj M
    Hum Immunol; 2009 Apr; 70(4):222-9. PubMed ID: 19272325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXP3 immunoregulatory gene variants are independent predictors of human papillomavirus infection and cervical cancer precursor lesions.
    Cezar-Dos-Santos F; Ferreira RS; Okuyama NCM; Trugilo KP; Sena MM; Pereira ÉR; Pereira APL; Watanabe MAE; de Oliveira KB
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2013-2025. PubMed ID: 31177386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor (TNF) alpha and interleukin (IL) 18 genes polymorphisms are correlated with susceptibility to HPV infection in patients with and without cervical intraepithelial lesion.
    Tavares MC; de Lima Júnior SF; Coelho AV; Marques TR; de Araújo DH; Heráclio Sde A; Amorim MM; de Souza PR; Crovella S
    Ann Hum Biol; 2016 May; 43(3):261-8. PubMed ID: 26079218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
    Chatterjee K; Dandara C; Hoffman M; Williamson AL
    BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.
    Gillio-Tos A; Bicalho Mda G; Fiano V; Grasso C; Tarallo V; De Marco L; Trevisan M; Xavier M; Slowik R; Carvalho NS; Maestri CA; Lacerda HM; Zugna D; Richiardi L; Merletti F
    BMC Cancer; 2012 Dec; 12():618. PubMed ID: 23265140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix.
    Ferguson R; Ramanakumar AV; Koushik A; Coutlée F; Franco E; Roger M;
    Int J Cancer; 2012 Aug; 131(3):E312-9. PubMed ID: 22095460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and genotype distribution of human papilloma virus in cervical squamous intraepithelial lesion and squamous cell carcinoma in Taizhou, China.
    Jin R; Yang X; Bao J; Zhang W; Dou R; Yuan D; Yang Q; Jiang L; Yu H
    Medicine (Baltimore); 2021 Jul; 100(28):e26593. PubMed ID: 34260540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of cervical intraepithelial lesions and cervical cancer is not influenced by SOD2 RS4880 polymorhism.
    Curti RRJ; Castilha EP; Bonaldo ALL; Okuyama NCM; Trugilo KP; Guembarovski RL; Couto-Filho JD; Watanabe MAE; de Oliveira KB
    Pathol Res Pract; 2022 Feb; 230():153742. PubMed ID: 34959097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigens I and II haplotypes associated with human papillomavirus 16-positive invasive cervical cancer in Mexican women.
    Hernández-Hernández DM; Cerda-Flores RM; Juárez-Cedillo T; Granados-Arriola J; Vargas-Alarcón G; Apresa-García T; Alvarado-Cabrero I; García-Carrancá A; Salcedo-Vargas M; Mohar-Betancourt A
    Int J Gynecol Cancer; 2009 Aug; 19(6):1099-106. PubMed ID: 19820376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
    Bontkes HJ; van Duin M; de Gruijl TD; Duggan-Keen MF; Walboomers JM; Stukart MJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ; Stevens FR; Dyer PA; Sinnott P; Stern PL
    Int J Cancer; 1998 Oct; 78(2):166-71. PubMed ID: 9754647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
    Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F
    Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response.
    Dong DD; Yang H; Li K; Xu G; Song LH; Fan XL; Jiang XL; Yie SM
    Reprod Sci; 2010 Aug; 17(8):718-23. PubMed ID: 20445010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-G 3'UTR polymorphisms in high grade and invasive cervico-vaginal cancer.
    Silva ID; Muniz YC; Sousa MC; Silva KR; Castelli EC; Filho JC; Osta AP; Lima MI; Simões RT
    Hum Immunol; 2013 Apr; 74(4):452-8. PubMed ID: 23228396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.
    Schlecht NF; Platt RW; Duarte-Franco E; Costa MC; Sobrinho JP; Prado JC; Ferenczy A; Rohan TE; Villa LL; Franco EL
    J Natl Cancer Inst; 2003 Sep; 95(17):1336-43. PubMed ID: 12953088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.